The Readout Loud

STAT
undefined
Jul 9, 2020 • 26min

Episode 119: Trump's FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine

Who will stand up to the White House? How can hospitals protect workers from Covid-19? And what ever happened with Biogen?
undefined
Jul 2, 2020 • 22min

Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?
undefined
Jun 25, 2020 • 23min

Episode 117: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus

Is this a second wave or a rising tide? Who’s the real GlaxoSmithKline whistleblower? And what happens to cancer care in a pandemic?
undefined
Jun 18, 2020 • 26min

Episode 116: Ezekiel Emanuel on vaccine politics & Tshaka Cunningham on diversifying genetic testing

Can a vaccine be an October surprise? Are journal publishers running a racket? And why is genetics so white?
undefined
Jun 11, 2020 • 21min

Episode 115: The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19

Can a virtual conference feel real? Do scientists have a say in their benefactors' business? And what does it take to get remdesivir in the U.S.?
undefined
Jun 4, 2020 • 23min

Episode 114: The killing of George Floyd, the drug industry's response, and what comes next

The killing of George Floyd at the hands of a white Minneapolis police officer has brutally underlined the systemic racism that informs policing, housing, education, and health care in the U.S. This podcast covers the world of biotech, which, like every facet of our society, is affected by racism and inequality. So, first, we talk about how the drug industry has responded to Floyd’s killing and what that response means. Then, we're joined for a conversation with longtime biotech executive Tony Coles, who is also a founding member of the Black Economic Alliance, a group of business leaders who raise money for candidates and causes. We talk about why Floyd's killing sparked global action, the relative value of public statements, and what business leaders can do to combat racism.
undefined
May 28, 2020 • 27min

Episode 113: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer

What happens after we get a coronavirus vaccine? Can virtual medical meetings replace the real thing? And wasn’t Amazon supposed to disrupt health care?
undefined
May 21, 2020 • 19min

Episode 112: Moderna's scant coronavirus data and the plight of the day trader

When is a press release worth $5 billion? Can biotech stocks replace sports? And how will we know if a coronavirus vaccine actually works?
undefined
May 14, 2020 • 27min

Episode 111: Covid-19 in the White House, a Parkinson’s experiment & public health lessons from porn

What can the adult film industry teach us about fighting coronavirus? Does the FDA approve Zoom backgrounds? And is it ethical to fund a study of yourself?
undefined
May 7, 2020 • 27min

Episode 110: Pandemic projections, Gilead's pricing dilemma & fighting Covid-19 in New York

What if the curve just stays flat? How much should a Covid-19 drug cost? And what's it like on the ground in the epicenter of the novel coronavirus?

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app